Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis

Survival outcomes of hepatic resection compared with transarterial chemoembolization or sorafenib for hepatocellular carcinoma with portal vein tumor thrombosis

Background/Aims:Treating hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT) remains controversial. We compared the outcomes of hepatic resection (HR), transarterial chemoembolization (TACE), and sorafenib therapy as treatments for HCC with PVTT. Methods:Patients diagnosed as HCC...

Full description

Bibliographic Details
Main Authors: Jung Min Lee, Byoung Kuk Jang, Yoo Jin Lee, Wang Yong Choi, Sei Myong Choi, Woo Jin Chung, Jae Seok Hwang, Koo Jeong Kang, Young Hwan Kim, Anil Kumar Chauhan, Soo Young Park, Won Young Tak, Young Oh Kweon, Byung Seok Kim, Chang Hyeong Lee
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2016-03-01
Series:Clinical and Molecular Hepatology
Subjects:
Hepatocellular carcinoma
Portal vein tumor thrombosis
Transarterial chemoembolization
Hepatic resection
Sorafenib
Online Access:http://e-cmh.org/upload/pdf/cmh-22-1-160.pdf

Internet

http://e-cmh.org/upload/pdf/cmh-22-1-160.pdf

Similar Items